Rule 1: Presence of the functional group "-CN" in the molecular structure may lead to adverse effects and potential toxicity. 
Rule 2: Presence of the functional groups "-COOH" or "-CONH2" in the molecular structure may lead to adverse effects; however, lack of prediction without them present. 
Rule 3: Presence of the metal ion magnesium (Mg) in the molecular structure may lead to adverse effects suggesting possible toxic nature.
Rule 4: Compounds containing a sulfonyl group (SO2R) or a carbonyl group (COR) in its structure are linked to side effects related to injury, poisoning, and procedural complications.
Rule 5: Compounds with a nitroso group (NO) or a diazo group (N2) in their structure typically do not have any side effects related to injury, poisoning, and procedural complications.
Rule 6: Compounds with a carboxylic acid group (COOH) or an ester group (COOR) in their structure may have side effects related to injury, poisoning, and procedural complications.
Rule 7: Presence of halogen atoms such as chlorine or bromine in a compound increases potential for toxicity due to their disruptive nature in biological systems.
Rule 8: Compounds containing functional groups such as sulfonyl groups (-SO2R) or nitro groups (-NO2) have higher risk of adverse effects due to interference in normal metabolic processes.
Rule 9: Compounds containing aromatic rings may increase likelihood of adverse effects due to interaction with biological molecules through π-π stacking interactions.
Rule 10: If the molecule contains a sulfonamide group (-SO2NH-), it may cause adverse effects related to injuries, poisonings, or procedural complications.
Rule 11: If the molecule contains a carbonyl group "C=O", then it may have the potential to cause adverse effects related to injuries, poisonings, or procedural complications.
Rule 12: If the molecule contains a halogen atom "X" where X is any halogen element), then it may cause adverse effects related to injuries, poisonings, or procedural complications.
Rule 13: If a compound contains sulfonyl group (SO2R) or a carbonyl group (COR) connected to a benzene ring, it may lead to side effects related to injury, poisoning, and procedural complications.
Rule 14: If a compound has nitro group (NO2) attached to an aromatic ring, it may lead to side effects related to injury, poisoning, and procedural complications.
Rule 15: If a compound contains a halogen atom such as chlorine (Cl) or fluorine (F) bonded to an aliphatic carbon chain, this does not necessarily indicate safety, as some compounds containing halogens have been associated with toxicity.
Rule 16: If the molecular structure contains a sulfonyl group (SO2R) or a nitro group (NO2), then it is likely to have side effects related to injury, poisoning, and procedural complications.
Rule 17: If the molecular structure has a heterocyclic ring system such as pyridine or pyrimidine, then it may have side effects related to injury, poisoning, and procedural complications.
Rule 18: If the molecular structure contains a halogen atom such as fluorine or chlorine, then it may not necessarily reduce chances of side effects related to injury, poisoning, and procedural complications.
Rule 19: Presence of functional groups such as sulfonamide, nitro, amide, and halogenated compounds in a compound may increase its potential for causing adverse effects.
Rule 20: Molecular weight and hydrophobicity may affect a compound's ability to interact with target receptors within the body, potentially leading to toxicity.
Rule 21: The stereochemistry of a compound can significantly impact its bioactivity and pharmacokinetic profile, potentially causing adverse effects.
Rule 22: If the molecular structure contains a functional group such as "CCON" or "CCSCN", then it may have side effects related to injury, poisoning, and procedural complications.
Rule 23: If the molecular structure contains a phosphorus atom bonded to two oxygen atoms and one carbon atom, it may cause adverse effects related to injury, poisoning, or procedural complications.
Rule 24: If the molecule contains a cyano group attached to a carbon atom adjacent to a double bond, it may have the potential to cause adverse effects related to injury, poisoning, or procedural complications.
Rule 25: A sulfur-containing compound may have the ability to cross-link proteins and cause tissue damage, leading to potential adverse effects. 
Rule 26: The presence of certain functional groups in a molecule may increase its likelihood of causing adverse effects if they interact with biological systems in ways that disrupt normal function or lead to toxicity.
Rule 27: The molecular weight and hydrophobicity of a compound can also influence its ability to cross cell membranes and reach target sites within cells. Molecules with high molecular weights and hydrophobicities tend to have lower aqueous solubilities and higher membrane permeabilities than those with low values for these parameters
Rule 28: The stereochemistry of a molecule can play a significant role in determining its biological activity and potential toxicity.
Rule 29: Presence of long carbon chain with multiple double bonds may have low water solubility and poor absorption when taken orally, hence increasing the risk of adverse effects.
Rule 30: If a molecule contains a functional group such as "CCCC(=O)O" or "CN1C=NC2=C1C(=O)N(C(=O)N2C)C", it may have potential for adverse effects.
Rule 1: Molecules with a chlorine atom bonded to a carbon atom likely to cause adverse effects in humans.
Rule 2: Molecules containing a nitro group (-NO2) have a high chance of causing adverse effects in humans.
Rule 3: The presence of a carbonyl group (-C=O) in a molecule's structure does not significantly impact the likelihood of it causing adverse effects in humans.
Rule 4: Molecules with a carbonyl group (C=O), likely to cause adverse effects related to injuries, poisonings, or procedural complications.
Rule 5: Molecules containing a benzene ring (C6H5) may potentially cause adverse effects related to injuries, poisonings, or procedural complications.
Rule 6: If a molecule contains a halogen atom such as fluorine (F), chlorine (Cl), bromine (Br), or iodine (I), it has the potential to cause adverse effects.
Rule 7: Molecules with a functional group such as "-NO2" or "-COOH" likely to cause adverse effects in humans.
Rule 8: Molecules containing a positively charged nitrogen atom bonded to two hydrogen atoms (i.e., NH2+) likely to cause adverse effects in humans.
Rule 9: Molecules containing a sulfur atom bonded to a positively charged oxygen atom (i.e., SO3^-) likely have low probability of causing adverse effects in humans.
Rule 10: Presence of functional groups such as sulfonyl group (-SO2R) or nitro group (-NO2) increases compounds potential for causing adverse effects.
Rule 11: Compounds with aromatic rings or conjugated double bonds may have higher chances of exhibiting toxicity.
Rule 12: The length and complexity of a compound's structure may play a role in determining its toxicity profile.
Rule 13: Molecule with iodine or calcium ions has no relation to causing adverse effects in injuries, poisonings, and procedural complications.
Rule 14: Molecules containing a sulfonyl group (-SO2-) may be related to causing adverse effects in injuries, poisonings, and procedural complications.
Rule 15: Compounds containing a nitro group (-NO2) might cause adverse effects in injuries, poisonings, and procedural complications.
Rule 16: Sulfonamide group (-SO2NH2) in compound might cause adverse effects related to injuries, poisonings, or procedural complications.
Rule 17: If the molecule contains a sulfonyl group (SO2R), it might cause adverse effects related to injuries, poisonings, or procedural complications.
Rule 18: Compounds containing a nitro group (NO2) have the potential to cause adverse effects related to injuries, poisonings, or procedural complications.
Rule 19: If a compound contains a functional group such as "-COOH" or "-OH", it might cause adverse effects in the body due to its ability to bind to proteins and other molecules.
Rule 20: If a molecule contains the substructure CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@@H]4CCOC4, it might cause adverse effects related to injuries, poisonings, or procedural complications.
Rule 21: Molecules containing a negatively charged oxygen atom bonded to two carbon atoms (i.e., a carboxylate group), may cause adverse effects related to injuries, poisonings, or procedural complications. 
Rule 22: Molecules containing a conjugated system of double bonds between carbon atoms may cause adverse effects due to their ability to interact with biological systems.
Rule 23: Heterocyclic ring structure containing nitrogen atoms present, likely to cause adverse effects related to injuries, poisonings, or procedural complications. 
Rule 24: If molecule contains a positively charged nitrogen atom bonded to two carbon atoms, a negatively charged oxygen atom attached to a carbon atom, then it might have potential to cause adverse effects.
Rule 25: If molecule contains a conjugated system consisting of a double bond and an adjacent carbonyl group and a benzene ring, then it might have potential to cause adverse effects.
Rule 26: Molecule containing a five-membered heterocyclic ring containing at least one nitrogen atom and a chlorine atom connected to a carbon, likely to cause adverse effects.
Rule 27: Molecules containing a negatively charged oxygen atom bonded to two carbon atoms in a ring structure might cause adverse effects in related to injury, poisoning or procedural complications.
Rule 28: Molecules with nitrogen atom bonded to three carbon atoms in a ring structure unlikely to cause adverse effects in related to injury, poisoning or procedural complications.
Rule 29: Molecules containing a fluorine atom attached to a benzene ring have higher likelihood of causing adverse effects associated with injuries, poisonings and procedural complications. 
Rule 30: Presence of functional group such as sulfonamide or nitro group in a compound may cause adverse effects.
Rule 31: If a compound contains a heterocyclic ring system, especially with nitrogen atoms, it may cause adverse effects.
Rule 32: Compound with multiple aromatic rings connected together through conjugated double bonds may cause adverse effects.
Rule 33: Molecules that contain a positively charged nitrogen atom bonded to two carbon atoms and one sulfur atom, and a negatively charged oxygen atom attached to a carbon atom have potential to cause adverse effects.
Rule 34: Molecules with a negatively charged oxygen atom bonded to two carbon atoms (carboxylate group) have potential to cause adverse effects.
Rule 35: Molecule contains a sulfonyl group (SO2R) may have the potential to cause adverse effects. 
Rule 36: Molecule contains a nitro group (NO2) may have the potential to cause adverse effects.
Rule 37: Molecules with benzene ring likely to cause adverse effects.
Rule 38: Molecules containing a nitro group (-NO2) or a halogen atom such as chlorine (Cl), bromine (Br), or iodine (I) are likely to cause adverse effects.
Rule 39: If molecule contains a sulfonyl group (SO2R) or a carbonyl group (C=O), it may cause adverse effects. 
Rule 40: Molecules containing a sulfonamide group (-SO2NH-) may cause adverse effects.
Rule 41: Molecules containing a nitro group (-NO2) may cause adverse effects if not necessary for the intended use.
Rule 42: Molecules with a chlorine atom bonded to a carbon atom may cause adverse effects.
Rule 1: The presence of a NO2 group in the structure might cause adverse effects.
Rule 2: The presence of a sulfonyl group (SO2) in the structure might cause adverse effects.
Rule 3: The presence of halogen atoms like chlorine or bromine in the structure may increase the compound's toxicity.
Rule 4: The presence of functional groups like "-COOH" or "-CONH2" in the molecular structure can likely cause adverse effects due to their binding ability to proteins and enzymes.
Rule 5: If a molecular structure contains aromatic rings, it increases the likelihood of causing adverse effects as these rings interact with biological systems.
Rule 6: If the molecular structure contains multiple polar functional groups, this may increase the solubility of the compound leading to increased absorption and potentially higher toxicity levels.
Rule 7: If a compound contains the functional group "-COOH", it may cause adverse effects such as irritation or inflammation.
Rule 8: Compounds containing aromatic rings may have the potential to cause adverse effects due to their stability and reactivity.
Rule 9: If a compound contains multiple bonds between carbon atoms, it may increase the likelihood of the compound causing adverse effects.
